Sanofi Draws Fire Over Cost of MS Drug Lemtrada

Sanofi draws fire over cost of MS drug Lemtrada

Filed under: drug treatment news 2011

The injectable drug, chemically known as alemtuzumab, was sold until September 2012 under the name Campath as treatment for leukemia and given more frequently at a higher dosage. "There is concern that with a license for multiple sclerosis, the cost of …
Read more on Chicago Tribune

UW Spinoff Resolve Therapeutics Snags .8M for Lupus Drug

Filed under: drug treatment news 2011

It's hard to diagnose, and very hard to treat with current drugs. Partly because of the lack of good therapies, and the huge potential market of 1.5 million estimatedpatients in the U.S., lupus has long been considered a big growth opportunity at Big …
Read more on Xconomy

Russian prostate drug market "set for 6% annual growth to 2016"

Filed under: drug treatment news 2011

Driven by an expanding patient population and the launches of a number of premium-priced branded treatments, the Russian market for drugs to treat prostate cancer is set to grow by around 6% each year to 2016, according to new forecasts. The total …
Read more on PharmaTimes

Drug users 'need better treatment'

Filed under: drug treatment news 2011

"We know that between April 2011 and March 2012, prescribed drug treatment, including but not exclusively methadone, was less than one-fifth of treatment options started. We want to ensure our services in Scotland are as effective as we can make them.
Read more on Irvine Herald